Not through an approved prescription yet, because retatrutide is still investigational
Understanding your peptide predisposition helps your prescriber select semaglutide, tirzepatide, or dual-peptide therapy most likely to work for your unique biology, reducing trial-and-error and maximizing treatment success from the start
What youll learn This guide walks through why compounded tirzepatide was pulled, how Mounjaro compares, and whether switching makes sense for your goals
Medical Weight Loss Panel Purpose: Assesses blood sugar control, metabolism, overall health, and organ function before starting treatment
The attrition bias and reporting bias were both low as no study was selectively reporting or with incomplete outcome data
A 2021 study published in The researchers found that 26% of people with the condition had diabetes